🚀 VC round data is live in beta, check it out!
Alibaba Health Valuation Multiples
Discover revenue and EBITDA valuation multiples for Alibaba Health and similar public comparables like Lenskart, BrightSpring Health, Wayfair, Nykaa and more.
Alibaba Health Overview
About Alibaba Health
Alibaba Health is of one of China's leading e-commerce platform specializing in healthcare-related products, including prescription drugs, OTC drugs, traditional Chinese medicine, health foods, and so on. The company operates both a third-party B2C service, or 3P, and its own direct-to-consumer business, or 1P, with its own inventory, which can both be accessed by Alibaba’s Tmall app and Alipay. The company also provides online consultation services in a separate app called Yilu or “Dr. Deer,” although its e-commerce businesses remain its core competency in the long-term. E-commerce accounted for 93% of revenue in fiscal year 2022. We estimate that AliHealth holds about 45% of market share in the industry in terms of GMV. AliHealth is 63.74% owned by its parent company, Alibaba Group.
Founded
1998
HQ
Employees
1.4K
Website
Financials (LTM)
EV
$8B
Alibaba Health Financials
Alibaba Health reported last 12-month revenue of $5B and EBITDA of $319M.
In the same LTM period, Alibaba Health generated $1B in gross profit, $319M in EBITDA, and $323M in net income.
Revenue (LTM)
Alibaba Health P&L
In the most recent fiscal year, Alibaba Health reported revenue of $4B and EBITDA of $238M.
Alibaba Health expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $5B | XXX | $4B | XXX | XXX | XXX |
| Gross Profit | $1B | XXX | $1B | XXX | XXX | XXX |
| Gross Margin | 24% | XXX | 24% | XXX | XXX | XXX |
| EBITDA | $319M | XXX | $238M | XXX | XXX | XXX |
| EBITDA Margin | 6% | XXX | 5% | XXX | XXX | XXX |
| EBIT Margin | 6% | XXX | 5% | XXX | XXX | XXX |
| Net Profit | $323M | XXX | $210M | XXX | XXX | XXX |
| Net Margin | 6% | XXX | 5% | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Alibaba Health Stock Performance
Alibaba Health has current market cap of $10B, and enterprise value of $8B.
Market Cap Evolution
Alibaba Health's stock price is $0.60.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $8B | $10B | 0.0% | XXX | XXX | XXX | $0.01 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialAlibaba Health Valuation Multiples
Alibaba Health trades at 1.6x EV/Revenue multiple, and 26.1x EV/EBITDA.
EV / Revenue (LTM)
Alibaba Health Financial Valuation Multiples
As of April 19, 2026, Alibaba Health has market cap of $10B and EV of $8B.
Equity research analysts estimate Alibaba Health's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Alibaba Health has a P/E ratio of 30.0x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $10B | XXX | $10B | XXX | XXX | XXX |
| EV (current) | $8B | XXX | $8B | XXX | XXX | XXX |
| EV/Revenue | 1.6x | XXX | 1.9x | XXX | XXX | XXX |
| EV/EBITDA | 26.1x | XXX | 35.0x | XXX | XXX | XXX |
| EV/EBIT | 26.8x | XXX | 36.0x | XXX | XXX | XXX |
| EV/Gross Profit | 6.6x | XXX | 7.6x | XXX | XXX | XXX |
| P/E | 30.0x | XXX | 46.1x | XXX | XXX | XXX |
| EV/FCF | 20.3x | XXX | 41.2x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Alibaba Health Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Alibaba Health Margins & Growth Rates
Alibaba Health's revenue in the last 12 month grew by 13%.
Alibaba Health's revenue per employee in the last FY averaged $3.3M, while opex per employee averaged $0.6M for the same period.
Alibaba Health's rule of 40 is 20% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Alibaba Health's rule of X is 40% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Alibaba Health Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 13% | XXX | 15% | XXX | XXX | XXX |
| EBITDA Margin | 6% | XXX | 5% | XXX | XXX | XXX |
| EBITDA Growth | 23% | XXX | 33% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 20% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 40% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $3.3M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.6M | XXX | XXX | XXX |
| S&M Expenses to Revenue | 7% | XXX | 7% | XXX | XXX | XXX |
| G&A Expenses to Revenue | 1% | XXX | 1% | XXX | XXX | XXX |
| R&D Expenses to Revenue | 2% | XXX | 2% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 19% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Alibaba Health Public Comps
See public comps and valuation multiples for other Pharmacies and Vertical E-commerce comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Alibaba Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Lenskart | XXX | XXX | XXX | XXX | XXX | XXX |
| BrightSpring Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Wayfair | XXX | XXX | XXX | XXX | XXX | XXX |
| Nykaa | XXX | XXX | XXX | XXX | XXX | XXX |
| Droga Raia | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Alibaba Health M&A Activity
Alibaba Health acquired XXX companies to date.
Last acquisition by Alibaba Health was on XXXXXXXX, XXXXX. Alibaba Health acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Alibaba Health
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialAlibaba Health Investment Activity
Alibaba Health invested in XXX companies to date.
Alibaba Health made its latest investment on XXXXXXXX, XXXXX. Alibaba Health invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Alibaba Health
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Alibaba Health
| When was Alibaba Health founded? | Alibaba Health was founded in 1998. |
| Where is Alibaba Health headquartered? | Alibaba Health is headquartered in China. |
| How many employees does Alibaba Health have? | As of today, Alibaba Health has over 1K employees. |
| Who is the CEO of Alibaba Health? | Alibaba Health's CEO is Difan Shen. |
| Is Alibaba Health publicly listed? | Yes, Alibaba Health is a public company listed on HKEX. |
| What is the stock symbol of Alibaba Health? | Alibaba Health trades under 00241 ticker. |
| When did Alibaba Health go public? | Alibaba Health went public in 1972. |
| Who are competitors of Alibaba Health? | Alibaba Health main competitors are Lenskart, BrightSpring Health, Wayfair, Nykaa. |
| What is the current market cap of Alibaba Health? | Alibaba Health's current market cap is $10B. |
| What is the current revenue of Alibaba Health? | Alibaba Health's last 12 months revenue is $5B. |
| What is the current revenue growth of Alibaba Health? | Alibaba Health revenue growth (NTM/LTM) is 13%. |
| What is the current EV/Revenue multiple of Alibaba Health? | Current revenue multiple of Alibaba Health is 1.6x. |
| Is Alibaba Health profitable? | Yes, Alibaba Health is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Alibaba Health? | Alibaba Health's last 12 months EBITDA is $319M. |
| What is Alibaba Health's EBITDA margin? | Alibaba Health's last 12 months EBITDA margin is 6%. |
| What is the current EV/EBITDA multiple of Alibaba Health? | Current EBITDA multiple of Alibaba Health is 26.1x. |
| What is the current FCF of Alibaba Health? | Alibaba Health's last 12 months FCF is $410M. |
| What is Alibaba Health's FCF margin? | Alibaba Health's last 12 months FCF margin is 8%. |
| What is the current EV/FCF multiple of Alibaba Health? | Current FCF multiple of Alibaba Health is 20.3x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.